Selexis Launches Biosimilar Cell Line Developme... (out Selexis: Selexis is a privately h...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Selexis Launches Biosimilar Cell Line Development Program

Date:3/30/2009

out Selexis:

Selexis is a privately held biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort and costs required to develop and maintain high-performance mammalian cell lines used in the expression of pharmaceutically relevant proteins (i.e. targets, MAbs, rProteins). The company's core intellectual property portfolio is based on the discovery and application of novel DNA based elements that control the dynamic organization of chromatin within all mammalian cells. Application of the Selexis Genetic Elements(TM) using the SURE Cell Line Development(SM) process has enabled the rapid development of high performance cell lines for a number of pharmaceutically important programs.

SOURCE Selexis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch
2. Merck Serono Launches Strategic Venture Capital Fund
3. Boston Scientific Launches New Coronary Imaging Catheter
4. LUMEDX Launches New Interventional Radiology Software
5. Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition
6. StartUpHire Launches Comprehensive Search Engine for Jobs at Venture-Backed Companies
7. PDHI Launches Short Form of Its ConXus Profile Health Assessment
8. Zymes Omega Solutions Bottles and Launches the Worlds First Omega-3 Enhanced Water
9. Irvine Scientific Launches IS CHO-CD XP(TM)
10. Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers
11. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting

Post Your Comments:

Breaking Biology Technology:Biomatrica Launches SampleWare 3.1 2 Biomatrica Launches SampleWare 3.1 3 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3 Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 2 Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum 3 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4

[0] Biomatrica Launches SampleWare 3.1 [0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years [0] Science Education Experts Discuss Solutions for Global Competitiveness at Scientific American Forum [0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea

Other Biology Technology:Beckman Coulter Announces First Quarter 2009 Results 2 Beckman Coulter Announces First Quarter 2009 Results 3 Beckman Coulter Announces First Quarter 2009 Results 4 Beckman Coulter Announces First Quarter 2009 Results 5 Beckman Coulter Announces First Quarter 2009 Results 6 Beckman Coulter Announces First Quarter 2009 Results 7 Beckman Coulter Announces First Quarter 2009 Results 8 Beckman Coulter Announces First Quarter 2009 Results 9 Beckman Coulter Announces First Quarter 2009 Results 10 Beckman Coulter Announces First Quarter 2009 Results 11 Beckman Coulter Announces First Quarter 2009 Results 12 Beckman Coulter Announces First Quarter 2009 Results 13 Beckman Coulter Announces First Quarter 2009 Results 14 Beckman Coulter Announces First Quarter 2009 Results 15 Beckman Coulter Announces First Quarter 2009 Results 16 Beckman Coulter Announces First Quarter 2009 Results 17 Beckman Coulter Announces First Quarter 2009 Results 18 Beckman Coulter Announces First Quarter 2009 Results 19 Beckman Coulter Announces First Quarter 2009 Results 20 Beckman Coulter Announces First Quarter 2009 Results 21 Beckman Coulter Announces First Quarter 2009 Results 22 Beckman Coulter Announces First Quarter 2009 Results 23 Beckman Coulter Announces First Quarter 2009 Results 24 Beckman Coulter Announces First Quarter 2009 Results 25 Beckman Coulter Announces First Quarter 2009 Results 26 Beckman Coulter Announces First Quarter 2009 Results 27 Beckman Coulter Announces First Quarter 2009 Results 28 Beckman Coulter Announces First Quarter 2009 Results 29 Shire plc: Results of the Annual General Meeting Held on April 28, 2009 2

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share Beckman Coulter Announces First Quarter 2009 Results Shire plc: Results of the Annual General Meeting Held on April 28, 2009

Breaking Biology News(10 mins):From fruit fly wings to heart failure -- why Not(ch)? 2 IGC scientist receives prestigious EMBO installation grant 2 Uniform analyses for clean drinking water in Europe 2 Webmedx Appoints New Senior Vice President of Client Development Chris Cashwell 52271 1 Webmedx Appoints New Senior Vice President of Client Development Chris Cashwell 52271 2 Hendrick Health System Deploys Sentillions Tap 26 Go Advanced Authentication Solution 52269 1 Hendrick Health System Deploys Sentillions Tap 26 Go Advanced Authentication Solution 52269 2 Hendrick Health System Deploys Sentillions Tap 26 Go Advanced Authentication Solution 52269 3 Major NIMH research project to test approaches to altering the course of schizophrenia 52267 1 Major NIMH research project to test approaches to altering the course of schizophrenia 52267 2 Major NIMH research project to test approaches to altering the course of schizophrenia 52267 3

[0] From fruit fly wings to heart failure -- why Not(ch)?[0] IGC scientist receives prestigious EMBO installation grant [0] Uniform analyses for clean drinking water in Europe

Other Biology News:Red alert! How disease disables tomato plant's 'intruder alarm' 2 September 2007 Sumatran earthquakes research findings 2 September 2007 Sumatran earthquakes research findings 3 BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use 2

Red alert! How disease disables tomato plant's 'intruder alarm'September 2007 Sumatran earthquakes research findings BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use

Biology Products:

Capillary Electrophoresis System from Agilent Technologies P/ACE™ MDQ Molecular Characterization System from Beckman Coulter Experion Spin Filters, 10 from Bio-Rad 55D Double Platform Shaker 12 x 16 from Reliable Scientific